Brief: Neuroscientific Biopharmaceuticals Partners With Linear Research For Phase I Clinical Study With Lead Drug Candidate Emtinb
22/06/2021 23:19
NeuroScientific Biopharmaceuticals Ltd NSB.AX :
* NEUROSCIENTIFIC BIOPHARMACEUTICALS PARTNERS WITH LINEAR
RESEARCH
FOR PHASE I CLINICAL STUDY WITH LEAD DRUG CANDIDATE EMTINB
Source text for Eikon: ID:nASX9pYzWl
Further company coverage: NSB.AX
Recent news on Miro Sciences
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO